Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarizotan for treatment-associated dyskinesia in Parkinson's disease
NCT00105521Phase 3Completed
- Sponsor
- EMD Serono
- Start
- Sep 2004
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sarizotan in dyskinesia, sponsored by EMD Serono. Started Sep 2004; status: completed.
02
Drugs
sarizotan
03
Conditions
dyskinesia
Beyond the preview
Go deeper on NCT00105521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00105521.